Candel Therapeutics, Inc.
CADL
$9.79
$0.323.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -54.42M | -38.18M | -22.76M | -22.14M | -39.58M |
| Total Depreciation and Amortization | 749.00K | 845.00K | 927.00K | 977.00K | 984.00K |
| Total Amortization of Deferred Charges | 622.00K | 360.00K | 149.00K | 190.00K | 231.00K |
| Total Other Non-Cash Items | 4.87M | -3.53M | -11.22M | -8.75M | 10.96M |
| Change in Net Operating Assets | 447.00K | 2.19M | -659.00K | -171.00K | 203.00K |
| Cash from Operations | -47.73M | -38.31M | -33.56M | -29.89M | -27.20M |
| Capital Expenditure | -1.26M | -587.00K | -181.00K | -37.00K | -12.00K |
| Sale of Property, Plant, and Equipment | 27.00K | 27.00K | 27.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.23M | -560.00K | -154.00K | -37.00K | -12.00K |
| Total Debt Issued | 47.95M | 47.95M | -- | -- | -- |
| Total Debt Repaid | -9.23M | -11.73M | -10.00M | -10.00M | -10.00M |
| Issuance of Common Stock | 113.76M | 20.58M | 114.99M | 119.16M | 103.67M |
| Repurchase of Common Stock | -693.00K | -693.00K | -693.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -178.00K | -- | -- |
| Cash from Financing | 151.78M | 56.10M | 104.12M | 109.16M | 93.67M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.82M | 17.23M | 70.41M | 79.23M | 66.45M |